BAILLIE GIFFORD & CO – Lyell Immunopharma, Inc. Transaction History
BAILLIE GIFFORD & CO portfolio value:
$5.53M
portfolio value
BAILLIE GIFFORD & CO quarter portfolio value change:
+12.42%
quarter
Lyell Immunopharma, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.70% | 47.44K shares | 920K | $7.33 | 755.10K |
| Q2 2022 | share | Decrease | -9.82% | -77.07K shares | 652K | $6.52 | 707.66K |
| Q1 2022 | share | Increase | +8.48% | 61.37K shares | -1.63M | $5.05 | 784.74K |
| Q4 2021 | share | Increase | +69.22% | 295.88K shares | -728K | $7.55 | 723.37K |
| Q3 2021 | share | Increase | +65.16% | 168.66K shares | 2.12M | $14.8 | 427.48K |
| Q2 2021 | share | Increase | 0.00% | 258.82K shares | 4.20M | $16.24 | 258.82K |